Photos of the week ending March 24, 2023 - Roll Call Photos of the week: Congress returned to Washington for a shortened work week this week. Roll Call · Mar 24, 2023
Moderna CEO grilled by Senate panel over planned price hike WASHINGTON — Moderna CEO Stéphane Bancel attempted on Wednesday to win over lawmakers irate about the company’s planned COVID-19 vaccine price increase, weathering a barrage of criticism from Democrats angry at the company’s profits from its groundbreaking mRNA vaccine. Tribune News Service · Mar 22, 2023
Senators press Moderna CEO on COVID-19 vaccine price hike Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price The Independent UK · Mar 22, 2023
Sunak’s tax return: the questions that remain unanswered Details of his blind management arrangement and what offshore interests the prime minister has are still unclear The Guardian - UK · Mar 22, 2023
Moderna faces criticism as it prices COVID vaccine at $130 per dose Pfizer has said it’s considering a similar price for its vaccine. Fortune · Mar 22, 2023
Moderna CEO grilled by Senate panel over planned price hike - Roll Call In a Senate hearing, Moderna's CEO tried to soothe lawmakers angry about plans to increase the cost of COVID-19 vaccines. Roll Call · Mar 22, 2023
Moderna paid the US more than enough for COVID shot partnership, executive says WASHINGTON — Moderna Inc. plans to tell U.S. lawmakers that it more than adequately compensated the government for its role in a COVID-19 vaccine partnership that brought the drugmaker billions of dollars, a central point in what’s likely to be a heated Capitol Hill hearing this week. Tribune News Service · Mar 21, 2023
Sanders: "Medicare for All" must wait As new chairman of the Senate HELP Committee, Sanders maps out his strategy for negotiating with GOP and Big Pharma Salon · Mar 9, 2023
Moderna's COVID vaccine gambit: Hike the price, offer free doses for uninsured Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help. WEKU · Mar 8, 2023
What are these 'cancer vaccines' I'm hearing about? And what similarities do they share with COVID vaccines? Barely a month goes by without headlines announcing yet another advancement in cancer vaccines. The Conversation · Mar 6, 2023
What are these ‘cancer vaccines’ making news? Are there similarities with COVID vaccines? Using the same mRNA technology as COVID vaccines, cancer vaccines are an emerging personalised treatment for cancer. The New Daily · Mar 6, 2023
Moderna eyes testing of mpox, bird flu vaccines in humans this year: 'They're really for public health' A shot against mpox would be valuable in case outbreaks reemerge, and the company sees bird flu as a “clear threat,” the company's president said. Fortune · Mar 6, 2023
Cramlington's Merit enlisted for £150m Moderna vaccine hub scheme Hundreds of construction jobs will be created through the Moderna Innovation and Technology Centre (MITC) project Birmingham Post · Mar 6, 2023
Is there a vaccine for RSV or respiratory syncytial virus? After almost 60 years, several come at once You might not have heard of respiratory syncytial virus, or RSV. But it caused more than 100,000 global deaths in 2019, making it a leading cause of death in children under one year old. The Conversation · Feb 26, 2023
ABC News · Feb 21, 2023 A new bivalent COVID-19 booster rolls out next month. Here's what you need to know about the vaccine All Australian adults who haven't had a COVID-19 booster or a confirmed case in the past six months are now eligible for an additional shot.
ABC News · Feb 17, 2023 Risk of COVID death or hospitalisation 88 per cent lower for those previously infected, study finds One of the largest studies conducted on COVID immunity finds that previous infections provide protection for as long as vaccination, but experts caution vaccines are still the safer option.
The Independent UK · Feb 16, 2023 Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.
Tribune News Service · Feb 16, 2023 Moderna won’t raise price on COVID vaccine after pressure Moderna said Wednesday it wouldn’t raise the price of its COVID-19 vaccine after a public outcry.
Reuters · Feb 15, 2023 U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.
Tribune News Service · Feb 9, 2023 Q&A: Why Bernie Sanders says his ‘Medicare for All’ dream must wait After railing at the injustices of U.S. health care for decades, Sen. Bernie Sanders in January became the new chairman of the Senate Health, Education, Labor & Pensions Committee. The job gives the health care industry’s biggest Washington nemesis an unprecedented opportunity to shape health care reform in Congress. But…
The Conversation · Feb 8, 2023 Haven't had COVID or a vaccine dose in the past six months? Consider getting a booster Australians aged 18 and over will be eligible for a COVID booster from February 20 if they have not had a vaccine dose or infection in the past six months.
Fortune · Feb 4, 2023 Cancer vaccines are already a reality—but your doctor might not tell you about them unless you ask “Patients need to advocate for themselves."
Tribune News Service · Feb 2, 2023 End of public health emergency causes cascade of changes WASHINGTON — The Biden administration’s plan to unwind the public health emergency tied to the COVID-19 pandemic will spur a whirlwind of changes related to telehealth, Medicaid, pharmaceuticals and other priorities.
Roll Call · Feb 2, 2023 End of public health emergency causes cascade of changes - Roll Call The public health emergency created an array of health flexibilities, impacting everything from Medicaid to telehealth coverage.
ABC News · Jan 31, 2023 Health department reviewing fifth COVID-19 vaccine. But what if you have missed a dose? The health department is expected to make a decision on the fifth dose within weeks. Here's what we know so far.